New automated cloud-ready solutions to enable customers to dramatically accelerate software development and validation. The companies are teaming up to increase the impact of the open-source library, ...
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
SAN FRANCISCO--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), today ...
Joint Solution to Drive Adoption of "Shift-Left" Software Development Methodologies with the Integration of Synopsys' Electronics Digital Twin Capabilities and Vector's Software Factory SUNNYVALE, ...
SAN FRANCISCO--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license ...
Vector and Synopsys are combining their SDV development capabilities to reduce development costs, facilitate faster development iterations, and enhance software quality from early compliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback